Proton pump inhibitors (PPIs) are very effective for short-term treatment of acid-related disorders like GERD, ulcers, and H. pylori therapy — but their long-term use isn’t without risk and shouldn’t be assumed safe by default.
During clinical postings, one thing I keep noticing on many case sheets is this that PPIs continued for weeks or even months… without a clear reason.
It’s almost prescribed “routinely.”
But Proton Pump Inhibitors (PPIs) aren’t meant to be lifelong medications for everyone.
Several studies and reviews show associations between prolonged PPI use and potential harms when not clearly indicated:
Increased risk of infections and fractures: Long-term PPI use has been linked to a higher incidence of Clostridioides difficile infections and bone fractures of the hip, wrist, and spine due to changes in gastric pH and mineral absorption. These risks have been highlighted in multiple observational studies and even by regulatory safety advisories.
Micronutrient deficiencies and kidney effects: Chronic PPI therapy may contribute to deficiencies such as hypomagnesemia and vitamin B12 deficiency, and observational data suggest associations with chronic kidney disease and electrolyte imbalances.
Cautious use recommended: Reviews and guideline discussions emphasize that long-term PPI therapy should be regularly evaluated and continued only when there’s a clear indication, with deprescribing considered when appropriate.
PPIs are not meant to be “forever pills.” Regular review of ongoing need, shortest effective duration, and careful indication can prevent unnecessary exposure to these potential risks.
Small checks like these improve patient safety more than we realize.
How often do you see PPIs continued without indication in your postings?
MBH/PS